Susan is a corporate commercial lawyer in Osler’s Health Industry and Cannabis groups. Susan regularly provides strategic advice to health industry stakeholders in connection with mergers and acquisitions, healthcare corporate restructurings and integrations, corporate governance matters, shareholders agreements, commercial agreements, outsourcing, clinical trial agreements and regulatory opinions in connection with federal and provincial health and cannabis statutes.
Susan has acted for a variety of health industry stakeholders from the early stages of planning through to initial public offerings or purchase and sale transactions. Examples of industries represented include digital health providers, regulated health professionals, pharmacies, pharmaceutical clients, hospitals, medical clinics, dental organizations, veterinary medicine, shared service organizations, long-term care homes, medical device reprocessing entities, licensed independent health facilities and laboratories, not-for-profits and registered charities and a variety of other private health clinics and health providers and health management and technology clients.
Susan regularly advises cannabis licence holders and other industry participants with navigating Canadian commercial operations within the cannabis regulatory environment, including licensing, supply agreements and promotional and advertising activities.
In response to COVID-19, Susan’s unique experience has enabled her to provide comprehensive advice in connection with emergency response measures, business opening and re-opening best practices, screening initiatives, including testing and vaccination procedures and matters relating to COVID-19 medical device authorization both for health industry participants and for businesses engaging with the health industry for the first time.